Objective: To detect the infection and drug resistance of Mycobacterium tuberculosis (MTB) in Chongqing and provide a scientific basis for the prevention and treatment of tuberculosis.
Introduction
Cancer-associated retinopathy (CAR) is a challenging clinical entity with often delayed diagnosis and difficult prognosis. The condition occurs in patients with typically known systemic malignancy but can precede cancer diagnosis. The clinical phenotype is varied, but typically includes optic nerve pallor, retinal vascular attenuation and visual field loss in the absence of obvious peripheral retinal abnormalities. Diagnosis is typically confirmed by serologic testing for anti-retinal antibodies. Numerous treatment options including systemic immune suppression with intravenous corticosteroids, intravenous immunoglobulins (IV Ig), and plasmapheresis have been used with mixed results. Even with treatment of the systemic malignancy, the prognosis typically involves worsening visual field loss. Anecdotal reports of intravitreal (intraocular) steroid injections have been able to demonstrate stability of visual field loss. This case report details the course of a patient with serologically confirmed cancer-associated retinopathy who showed initial improvement and later stabilization of visual acuity, optic nerve structure and function after a single intravitreal steroid injection in one eye.
Materials and Methods

Research population
From January 2014 to September 2017, the sputum, urine, pleural effusion, cerebrospinal fluid, and puncture fluid samples were collected from 6557 suspected TB patients (18-75 years) in The First Affiliated Hospital of Chongqing Medical University. All the patients were negative for hepatitis B virus, hepatitis C virus, human immunodeficiency virus (HIV),combined tumor and other symptoms of liver damage. This study was approved by the Institutional Review Board (IRB) committee of The First Affiliated Hospital of Chongqing Medical University.
Written consent given by the patients was waived by the approving IRB.
Detection by DNA microarray chip
This study was based on the designing of oligonucleotide probes which can specifically detect the specific gene site of Mtb, and the mutations on the promoter of rpoB, KatG and inhA. Briefly, the DNA microarray chip technique (20) was used to test mutations in the rpoB gene at the 511, 513, 526, 531 and 533 codons. Common mutation sites to give an indication of RFP resistance. For INH resistance, the katG315 and inhA-15 mutation sites were assessed. The Mtb population detection kit and GeeDom Mtb drug detection kits (CapitalBio Corporation, Beijing, China) were operated according to the instruction of manufactory. The nucleic acid was extracted and PCR amplification. Once combined with a hybridization buffer (CapitalBio Corporation), the products were placed in a BioMixer chip hybridization instrument (CapitalBio Corporation) for hybridization. Then products were put in a slidewasher 8 chip dry cleaning instrument (CapitalBio Corporation) for washing and drying.Finally, the chip was placed in chip identification system (CapitalBio Corporation) for scanning and interpretation (LuxScanTM 10K/B software, CapitalBio Corporation).
Statistical analysis
Mann-Whitney U tests of SSPS12.0 (SPSS, Inc., Chicago, IL, USA) were used to assess the difference between different groups. A two-tailed P<0.05 was considered statistically significant. The distribution of the study variables was calculated using means with standard deviations for normal continuous variables or using median with quartile range for skewness variables, and frequencies and percent for categorical variables. For continuous variable comparisons, Student's t tests were used when equality of variances was satisfied, otherwise Satterthwaite-tests were conducted. We assessed effect of each "risk" factor for TB using binary logistic regression. Stepwise logistic regression was performed in this study. 
Results
Mtb positive patients and positive types distribution
The mutation site of ropB, katG and inhA gene
The Table 4 showed the people with ropB gene mutation were 72 patients. Of these, the patients with single mutation were 68, double mutations were 3 patients, and triple mutations were 2 patients. The highest mutation site was 531 (TCG) locus (37.5%, 27/72). The people with katG and inhA gene mutation were 50 patients. Of these, the katG and inhA gene mutation ratio were 44.0% (22/50) and 42% (21/50), respectively. Meanwhile, both catch and inhale gene mutation ratio was 14% (7/50). The most common mutation site was 315 (AGC) locus. Table 4 : The distribution of ropB, inhale, katG gene mutation
Gene
The risk factor analysis of drug-resistant Mtb
The Table 5 demonstrated the age, marital status, cavity, history of treatment, and regular medication were statistically different between drug-resistant and control group (drug-sensitivity) (P<0.05). Otherwise, educational level and occupation have no difference between drug-resistant and control group (drug-sensitivity) (P>0.05).
Social demographic characteristics Case group (%) n=122
Control group (%) n=985 
Discussion
The spread of Mtb seriously affected the people in the world. Moreover, the drug-resistant Mtb and its co-infection with HIV have seriously affected TB prevention and treatment [11] . Inherently, this has meant deterioration in the control of epidemics.
RFP and INH are primarily first-line anti-TB drugs. However, the effectiveness of the drugs has been greatly affected by the increase in drug resistance. A previous study has also suggested that in TB clinical strains demonstrate high levels of RFP (13.3%), INH (24.6%), and multi-drug (10.5%) resistance [5] .
The most of RFP resistance related gene mutations located in the rpoB gene. The mutations on the 531 Ser, 526 His and 516 Asp codons accounted for 85% of the strains resistant to drugs. INH is another first-line anti-TB drug that is used together with RFP. Most INH resistance related to gene mutation were identified in the katG315 and inhA-15 mutations [11] . The primary mutation mechanism of INH-resistance in the MTB katG gene investigated was 315 AGC→ACC, Ser→Thr (S315T).
We detected the suspected Mtb patients in Chongqing using gene chip method and the positive ration was 16.89 %.
The general ratio of INH-resistant and RFP-resistant was 11.02 %,which was less than 13.49% in the report of Pang Y et al. [13] . The reason might be that we recruited new patients not retreatment patients. The Mtb infected male accounted for 73.98% and female accounted for 26.12%.The most Mtb infected people were men and the ratio of infected men/women was 2.5. The data showed no difference with the report of Pang Y et al. [13] . Our report demonstrated the history of treatment was the risk factor of the drug-resistant , which consisted with the report of the report of Lomtadze N et al. [14] . Moreover, irregular medication was another risk factor, which consisted with the report of the report of DIANDÉ S et al. [15] . The irregular medication caused disease relapse and drug-resistant Mtb became the dominant bacteria. The cavity was also another risk factor in our report, which In accordance with the study of Ahmad AM et al. [16] . There were lots of drug-resistant Mtb in the cavity, so the Mtb might spread easily.
Our report demonstrated the infected ratio and the drug resistant types of Mtb in Chongqing district. The risk factors associated with drug resistant are complex; we should reinforce early detection, rapid diagnosis, and standardize therapy, in order to make sure that the patients take the full course of the treatment to reduce the risk of drug resistant types of Mtb.
